Li Tong, Yang Jue, Lv Xiaobo, Liu Kunmei, Gao Chao, Xing Yingying, Xi Tao
School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, People's Republic of China,
Biotechnol Lett. 2014 Sep;36(9):1743-52. doi: 10.1007/s10529-014-1540-3. Epub 2014 May 4.
MicroRNAs play important roles in carcinogenesis by negatively regulating the expression of target genes. Here we explore the biological function of miR-155 and the underlying mechanism in colorectal carcinoma. We validate, for the first time, that E2F2 is a direct target of miR-155 using western blot and a luciferase reporter assay and that miR-155 regulates the proliferation and cell cycle of colorectal carcinoma cells by targeting E2F2 using siRNA technology. We also found, for the first, time that E2F2 acts as a tumor suppressor in colorectal carcinoma. Overall, miR-155 plays an important role in colorectal carcinoma tumorigenesis by negative regulation of its targets including E2F2 and may be a potential therapeutic target for colorectal carcinoma treatment.
微小RNA通过负向调节靶基因的表达在肿瘤发生过程中发挥重要作用。在此,我们探讨了miR-155在结直肠癌中的生物学功能及其潜在机制。我们首次使用蛋白质免疫印迹法和荧光素酶报告基因检测法验证E2F2是miR-155的直接靶标,并使用小干扰RNA技术通过靶向E2F2来调节结直肠癌细胞的增殖和细胞周期。我们还首次发现E2F2在结直肠癌中作为一种肿瘤抑制因子发挥作用。总体而言,miR-155通过负向调节包括E2F2在内的靶标在结直肠癌肿瘤发生中起重要作用,并且可能是结直肠癌治疗的一个潜在治疗靶点。